These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3521848)

  • 1. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Birch R
    Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
    [No Abstract]   [Full Text] [Related]  

  • 4. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Bartolucci A
    Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitoxantrone in advanced renal cancer: a phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    van Oosterom AT; Fosså SD; Pizzocaro G; Bergerat JP; Bono AV; De Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1239-41. PubMed ID: 6541582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Weinerman BH; Eisenhauer EA; Besner JG; Coppin CM; Stewart D; Band PR
    Cancer Treat Rep; 1986 Jun; 70(6):751-4. PubMed ID: 3524824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of elliptinium in advanced renal cell carcinoma.
    Caillé P; Mondesir JM; Droz JP; Kerbrat P; Goodman A; Ducret JP; Theodore C; Spielman M; Rouëssé J; Amiel JL
    Cancer Treat Rep; 1985; 69(7-8):901-2. PubMed ID: 4016798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
    Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential cardiotoxicity with mitoxantrone.
    Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G
    Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of mitoxantrone in patients with primary liver cancer.
    Falkson G; Coetzer BJ; Terblanche AP
    Cancer Treat Rep; 1984 Oct; 68(10):1311-2. PubMed ID: 6525607
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of taxol in patients with metastatic renal cell carcinoma.
    Einzig AI; Gorowski E; Sasloff J; Wiernik PH
    Cancer Invest; 1991; 9(2):133-6. PubMed ID: 1677827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
    Wagner H; Possinger K; Bremer K; Donhujsen-Ant R; Peukert M; Queisser W
    Cancer Treat Rep; 1987 Feb; 71(2):209-10. PubMed ID: 3802118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.